To further our mission, we annually award research grants to institutions and medical professionals whose research focuses on cancers that present the greatest opportunities for a homerun cancer cure.
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
The Cure Starts Now has funded $21,325,827 in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 135 grants at over 100 hospitals in 17 countries.
Institute of Cancer Research - $102,432
Combinational strategies alongside ACVR1 inhibition in DIPG
The Regents of the University of California - $70,000
An Open Label Single Arm Phase I/II study of MTX110 delivered by convection-enhanced delivery (CED) in patients with diffuse intrinsic pontine glioma (DIPG) previously treated with external beam radiation therapy
The Hospital for Sick Children - $100,560
MRI Guided Focused Ultrasound: Towards Clinical Translation in Diffuse Intrinsic Pontine Glioma (DIPG)
Texas Children's Hospital and Ann & Robert H. Lurie Children's Hospital of Chicago - $200,000
Targeting DIPG through Combining a Super-activator (MCB-613) of Steroid Receptor Co-activators with Radiation.
Gustave Roussy - $101,868
Elucidating the underlying mechanisms of radio resistance at diagnosis and relapse in DIPG
Ospedale Pediatrico Bambino Gesu - $98,987
Investigating the role of DIPG-derived exosomes in tumor growth and invasion
Memorial Sloan Kettering Cancer Center - $100,000
Targeting EZH2 as a therapeutic strategy in DIPG
Dana-Farber Cancer Institute - $100,000
Defining the Cellular Architecture of Diffuse Intrinsic Pontine Glioma through Large-Scale Single-cell RNA-sequencing analyses
The Hospital of Sick Children - $162,828
Targeting DIPG through pharmacological activation of mitochondrial biogenesis: an in vitro and in vivo preclinical study
Stanford University - $200,000
Targeting neuronal activity regulated DIPG infiltration
Children's Cancer Institute (AU) - $185,706
Developing novel combination therapeutic approaches for DIPG targeting Polo-like Kinase 1
Children's National Medical Center - $200,000
Validation of TAK228 as an effective drug for treating children with DIPG
Ann & Robert H. Lurie Children's Hospital - $100,000
Determine the efficacy of BMP and MEK inhibitors with RT to treat ACVR1 mutant DIPG
Anschutz Medical Campus - $50,000
Toward a Multimodality Cure for DIPG: Investigation of Intratumoral Drug Penetration and Craniospinal Irradiation.
Massachusetts General Hospital - $50,000
Repurposing Mefloquine for Diffuse Intrinsic Pontine Glioma Therapy